ATE357249T1 - Auf bläschen basierendes impfstoff gegen chlamydia - Google Patents

Auf bläschen basierendes impfstoff gegen chlamydia

Info

Publication number
ATE357249T1
ATE357249T1 AT02712901T AT02712901T ATE357249T1 AT E357249 T1 ATE357249 T1 AT E357249T1 AT 02712901 T AT02712901 T AT 02712901T AT 02712901 T AT02712901 T AT 02712901T AT E357249 T1 ATE357249 T1 AT E357249T1
Authority
AT
Austria
Prior art keywords
compositions
bubble
vaccine
field
chlamydia vaccine
Prior art date
Application number
AT02712901T
Other languages
English (en)
Inventor
Jacqueline Berthet
Yves Lobet
Jan Poolman
Vincent Verlant
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE357249T1 publication Critical patent/ATE357249T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02712901T 2001-02-08 2002-02-08 Auf bläschen basierendes impfstoff gegen chlamydia ATE357249T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0103169.9A GB0103169D0 (en) 2001-02-08 2001-02-08 Vaccine composition

Publications (1)

Publication Number Publication Date
ATE357249T1 true ATE357249T1 (de) 2007-04-15

Family

ID=9908382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02712901T ATE357249T1 (de) 2001-02-08 2002-02-08 Auf bläschen basierendes impfstoff gegen chlamydia

Country Status (10)

Country Link
US (2) US20040131625A1 (de)
EP (1) EP1383534B1 (de)
JP (1) JP2004527480A (de)
AT (1) ATE357249T1 (de)
AU (1) AU2002244710A1 (de)
CA (1) CA2436435A1 (de)
DE (1) DE60218998T2 (de)
ES (1) ES2284840T3 (de)
GB (1) GB0103169D0 (de)
WO (1) WO2002062380A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US20020061848A1 (en) * 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US20080213264A1 (en) * 1998-12-08 2008-09-04 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6919187B2 (en) * 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
ES2519440T3 (es) 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
US7537772B1 (en) * 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US7731980B2 (en) 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
EP2172213B1 (de) 2003-01-30 2013-04-03 Novartis AG Injizierbarer Impfstoff gegen multiple Meningokokken-Serogruppen
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
AU2004291576A1 (en) * 2003-11-20 2005-06-02 Sanofi Pasteur Limited Immunization against Chlamydia infection
CA2577165C (en) * 2004-08-17 2015-01-27 Hunter Immunology Pty Limited Oral killed vaccines and method for providing same
WO2006050571A1 (en) * 2004-11-11 2006-05-18 Queensland University Of Technology Chlamydia antigens and uses thereof
WO2006081259A2 (en) 2005-01-27 2006-08-03 Children's Hospital & Research Center At Oakland Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
WO2006104890A2 (en) * 2005-03-31 2006-10-05 Glaxosmithkline Biologicals Sa Vaccines against chlamydial infection
WO2007030879A1 (en) * 2005-09-13 2007-03-22 Diatech Pty Ltd Diagnostic markers and uses therefor
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
US9259463B2 (en) * 2006-01-16 2016-02-16 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Chlamydia vaccine
CN102356089B (zh) 2008-02-21 2014-02-19 诺华股份有限公司 脑膜炎球菌fHBP多肽
UA99659C2 (uk) * 2008-05-30 2012-09-10 Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
CA2737684A1 (en) * 2008-10-08 2010-04-15 Immune Solutions Limited Oral vaccines for producing mucosal immunity
EP2413959A4 (de) * 2009-01-29 2013-06-19 British Columbia Cancer Agency Chlamydia-antigene umfassende zusammensetzungen
CN102596240B (zh) 2009-08-27 2015-02-04 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
CA2779816A1 (en) 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
GB201009861D0 (en) 2010-06-11 2010-07-21 Novartis Ag OMV vaccines
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
KR20160127104A (ko) 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
RU2017115114A (ru) * 2014-10-02 2018-11-05 Нитто Денко Корпорейшн Фармацевтическая композиция вакцины для чрескожного введения
HK1248554A1 (zh) * 2015-02-20 2018-10-19 Board Of Regents, The University Of Texas System 作为疫苗和载体的减毒衣原体的方法和组合物
CN120813371A (zh) 2023-03-02 2025-10-17 赛诺菲巴斯德有限公司 用于在衣原体病的治疗中使用的组合物
WO2025240926A1 (en) * 2024-05-17 2025-11-20 University Of Iowa Research Foundation Neisseria gonorrhoeae vaccines and treatments and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180111B1 (en) * 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
US6558677B2 (en) * 1996-10-15 2003-05-06 Wendell D. Zollinger Vaccine against gram negative bacteria
US6607730B1 (en) * 1998-11-02 2003-08-19 Aventis Pasteur Limited/Aventis Pasteur Limitee Chlamydia antigens and corresponding DNA fragments and uses thereof
US6565856B1 (en) * 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU2001264935A1 (en) * 2000-05-24 2001-12-03 University Of Maryland Biotechnology Institute Method for introducing and expressing genes in animal cells, and bacterial blebsfor use in same

Also Published As

Publication number Publication date
EP1383534A2 (de) 2004-01-28
US20040131625A1 (en) 2004-07-08
AU2002244710A1 (en) 2002-08-19
EP1383534B1 (de) 2007-03-21
WO2002062380A3 (en) 2003-10-23
GB0103169D0 (en) 2001-03-28
DE60218998T2 (de) 2007-12-06
US20050281847A1 (en) 2005-12-22
ES2284840T3 (es) 2007-11-16
JP2004527480A (ja) 2004-09-09
DE60218998D1 (de) 2007-05-03
CA2436435A1 (en) 2002-08-15
WO2002062380A2 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
ATE357249T1 (de) Auf bläschen basierendes impfstoff gegen chlamydia
WO2002009746A8 (en) Vaccines comprising outer membrane vesciles from gram negative bacteria
CY1117164T1 (el) Φαρμακευτικες συνθεσεις περιλαμβανουσες κολλοειδες διοξειδιο πυριτιου
HUP0203056A1 (hu) Vakcinakészítmény
DE60110822D1 (de) Zubereitung zur immunisierung gegen den aids-virus
DE69940404D1 (de) Multikomponenten Impfstoffe gegen Staphylococcus aureus
EP1594536A4 (de) Adjuvante influenza-vakzine
IL161229A0 (en) Methods and compositions relating to restricted expression lentiviral vectors and their applications.
EP2311488A3 (de) Impfstoffzusammensetzung
CY1112014T1 (el) Συνθεσεις αντιβακτηριακων εμβολιων
MXPA03011505A (es) Composiciones para cabello.
JP2001131087A5 (de)
EP1423137A4 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
DK1425037T3 (da) Bakteriel vaccine
WO2005035558A3 (en) Piscirickettsia salmonis antigens and use thereof
JP2006512078A5 (de)
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
JP2003528637A5 (de)
DE60235809D1 (de) Nukleinsäurefreie ghost zusammensetzungen
WO2006113907A3 (en) Escherichia coli o157:h7 proteins and uses thereof
WO2002057281A3 (en) Aminoglycosides as antibiotics
MXPA03010821A (es) Composiciones de aroma y fragancias.
DK1660121T3 (da) Levende svækket bakteriel vaccine
DE69534280D1 (de) Orale impfstoffe gegen yersinia pestis infektionen
BRPI0414884A (pt) derivados 3-isopropil-1-metilciclopentila e seu uso em aplicações com fragráncias

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties